PMA device
Paradigm Real Time ? MMT-522/722 Insulin Pump
Medtronic Minimed · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Apr 7, 2006, newest Oct 16, 2006Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
41
Naming "Paradigm Real Time"
MAUDE reports
327,505
Brand "Paradigm Real Time", since 2015
PubMed studies
14
Mentioning "Paradigm Real Time"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Paradigm Real Time ? MMT-522/722 Insulin Pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- PARADIGM REAL TIME ? MMT-522/722 INSULIN PUMPPMA supplement
P980022-S016 · Decided Oct 16, 2006 · 228 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- PARADIGM REAL TIME SYSTEMPMA supplement
P980022-S013 · Decided Apr 7, 2006 · 185 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Paradigm Real Time", any status and sponsor, newest update first.
National Institute of Neurological Disorders and Stroke (NINDS)NIH
NCT01019343 · 1,273 participants · Start Dec 8, 2009 · Primary completion Aug 17, 2016
Device: Eye-tracking Device; Pulsed vibrator and 3 more · For: Parkinson's Disease; Tourette's Syndrome; Tic Disorders and 2 more
Sites: Bethesda, Maryland
University of UlsterAcademic, hospital or other
NCT04307108 · 111 participants · Start Nov 11, 2018 · Primary completion Mar 30, 2020
Device: Magic Glass · For: Stroke
Sites: Ancona, Italy; Londonderry, United Kingdom; Lurgan, United Kingdom
- Endometriosis and MigraineRecruiting
Washington University School of MedicineAcademic, hospital or other
NCT06785129 · 120 participants (planned) · Start Feb 12, 2025 · Primary completion Jan 1, 2028
Device: Thermal stimuli; Pressure stimuli · For: Migraine; Endometriosis
Sites: St Louis, Missouri
38 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Paradigm Real Time", and for the whole product code for context.
This brand
327,505 reports: 249,152 malfunction, 77,068 injury, 1,245 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
Medtronic Puerto Rico Operations Co.
2032227-2026-264782 · Received Oct 30, 2026 · Event dated Oct 9, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Mechanical Problem; Obstruction of Flow
Patient problem as coded: Hyperglycemia; Malaise
Medtronic Puerto Rico Operations Co.
2032227-2026-263573 · Received Oct 29, 2026 · Event dated Oct 22, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Display or Visual Feedback Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Medtronic Puerto Rico Operations Co.
2032227-2026-263628 · Received Oct 29, 2026 · Event dated Oct 22, 2026
Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Device problem as coded: Display or Visual Feedback Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722)Open, Classified
Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)Open, Classified
Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
11 more recall records with a free account
Published research
The most relevant PubMed records for "Paradigm Real Time"[tiab]. The summary above synthesizes these.
- The integrated MiniMed Paradigm REAL-Time insulin pump and glucose monitoring system: implications for improved patient outcomes.
Mastrototaro J, Lee S · Diabetes Technol Ther · 2009
- Low-frequency fluctuation in continuous real-time feedback of finger force: a new paradigm for sustained attention.
Dong ZY, Liu DQ, Wang J, et al. · Neurosci Bull · 2012Research Support, Non-U.S. Gov't
- [Therapeutic education and continuous glucose monitoring in insulin-treated diabetic patients].
Thielen V, Radermecker RP, Renard E, et al. · Rev Med Suisse · 2010English Abstract
- Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D, Sulmont V, Reznik Y, et al. · Diabetes Care · 2009Multicenter Study, Randomized Controlled Trial
- Rosiglitazone Attenuates Memory Impairment in Aged Rat with Diabetes by Inhibiting NF-kappa B Signal Pathway Activation.
Fei L, Yong-Jun H, Zhang-Min M, et al. · Exp Clin Endocrinol Diabetes · 2015Research Support, Non-U.S. Gov't
- Accuracy of a new real-time continuous glucose monitoring algorithm.
Keenan DB, Cartaya R, Mastrototaro JJ · J Diabetes Sci Technol · 2010Evaluation Study, Multicenter Study
- Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
Petrovski G, Dimitrovski C, Bogoev M, et al. · Diabetes Technol Ther · 2011Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study.
Mastrototaro JJ, Cooper KW, Soundararajan G, et al. · Adv Ther · 2006
- Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
Hermanides J, Nørgaard K, Bruttomesso D, et al. · Diabet Med · 2011Comparative Study, Multicenter Study
- Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.
Buckingham BA, Cameron F, Calhoun P, et al. · Diabetes Technol Ther · 2013Comparative Study, Multicenter Study
- Subcutaneous open-loop insulin delivery for type 1 diabetes: Paradigm Real-Time System.
Pohar SL · Issues Emerg Health Technol · 2007Research Support, Non-U.S. Gov't
- Acceptability and utility of the mySentry remote glucose monitoring system.
Kaiserman K, Buckingham BA, Prakasam G, et al. · J Diabetes Sci Technol · 2013Clinical Trial, Multicenter Study
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.